The Ebola patient in Dallas who received an experimental Chimerix drug died Wednesday, but infectious-disease researchers keen for any new tool to fight the widening viral outbreak said it was premature to rule out the drug’s potential to treat Ebola.
Researchers aren't ruling out treatment used in Dallas case
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.